Comparison of phenotypic and genotypic methods for Pyrazinamide susceptibility testing

Indian Journal of Tuberculosis

Volumn 56, Issue 2, 2009, Pages 82-90

  Shenai, Shubhada ^a   Rodrigues, Camilla ^a   Sadani, Meeta ^a   Sukhadia, Nesline ^a   Mehta, Ajita ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

M. tuberculosis; PncA gene mutations; Pyrazinamide susceptibility

Indexed keywords

BACTERIAL PROTEIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; PNCA PROTEIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; GENE MUTATION; GENOTYPE; INFECTION RATE; MULTIDRUG RESISTANCE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS;

AMIDOHYDROLASES; ANTITUBERCULAR AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PYRAZINAMIDE; TUBERCULOSIS;

EID: 67650085846     PISSN: 00195707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Heifets L and Lindholm-Levy P. Pyrazinamide sterilizing activity in vitro against semi-dormant Mycobacterium tuberculosis bacterial populations. Am Rev Respir Dis 1992; 145:1223-5
2. Mitchison DA. The action of anti-tuberculosis drugs in short-course chemotherapy. Tubercle 1985; 66:219-25.
3. Scorpio A, Zhang Y. Mutations in pncA, a gene encoding Pyrazinamidase/nicotinamidase, cause resistance to the anti-tuberculous drug pyrazinamidase in tubercle bacillus. Nat Med 1996; 2: 662-667.
4. Hirano K, Takahashi M, Kazumi Y, Fukasawa Y, Abe C. Mutation in pncA is a major mechanism of pyarazinamide resistance in Mycobacterium tuberculosis. Tubercle Lung Dis 1998; 78:117-122.
5. Scorpio A, Lindholm-Levy PL, Heifeits L, Gilman R, Siddiqi S, Cyanmon M and Zhang Y. Characterization of pncA mutations in pyrazinamide Mycobacterium tuberculosis. Anti-Microbial Agents Chemother 1997; 41(3): 540-543
6. Screevatsan S, Pan X, Zhang Y, Kreiswirth BN, Musser JM. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob Agents Chemother 1997; 41:636-640.
7. Konno K, Feldmann FM, McDermott W. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respir Dis 1967; 95:461-469.
8. Krishnamurthy A, Almeida D, Rodrigues C and Mehta A. Comparison of pyrazinamide drug susceptibility of M. tuberculosis by radiometric BACTEC and enzymatic pyrazinamidase assay. Indian J Med Microbiol 2004
9. Wayne LG. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am Rev Respir Dis 1974; 109:147-151.
10. Scropio AD, Collins D, Whipple D, Cave D, Bates J and Zhang Y. Rapid differentiation of bovine and human tubercle bacilli based on a characteristic mutation in the bovine pyrazinamidase gene. J Clin Microbiol 1997; 35:106-110.
11. Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and Epidemiology. J Clin Microbiol 1997; 35: 907-914.
12. Salfinger M and Kafader FM. Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. Zentralblall fur bakteriologie, Mikrobiologie, und Hygiene Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology 1987; 265, 404-407.
13. Butler WR and Kilburn JO. Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity. Anti-micob agents chemothe 1983; 24:600-601.
14. Lee KW, Lee JM and Jung KS. Charcterization of pncA mutations of Pyrazinamide - resistant Mycobacterium tuberculosis in Korea. J Korean Med Sci 2001; 16:537-543.
15. Butler WR and Kilburn JO. Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Clin Microbiol 1982; 16(6):1106-1109.
16. Scarparo C, Ricordi P, Ruggiero G and Piccoli P. Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to PZA, Streptomycin, Isoniazid, Rifampicin and Ethambutol and comparison with radiometric BACTEC 460 TB method. J Clin Microbiol 2004; 42(3):1109-1114.
17. Pfyffer GE, Palicova F and rusch_Gerdes. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the radiometric BACTEC MGIT 960 system. J Clin Microbiol 2002; 40:1670-1674.
18. Kontos F, Nicolaou S, Kostopoulos C, et al. Multicenter evaluation of the fully automated BACTEC MGIT 960 system for susceptibility testing of Mycobacterium tuberculosis to Pyrazinamide:comparison with the radiometric BACTEC 460 TB system. J Microbiol Mtd 2003; 55(1):331-333.
19. Miller MA and Thibert L, Desjardins F, Siddiqi SH and Dascal A. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide: comparison of BACTEC method with pyrazinamidase assay. J Clin Microbiol 1995; 33:2468-2470
20. Chaeng SJ, Thibert L, Sanchez T, Heifets L, Zhang Y. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec. Canada. Anti-microb Agents Chemother 2000; 44:528-532
21. Marttila HJ, Mariamaki M, Vyshnevsksya E, et al. pncA mutations in pyrazimamide - resistant Mycobacterium tuberculosis isolates from Northwetern Russia. Antimicrob Agent Chemother 1999; 43:1764-1766.
22. Louw GE, Warren RM, Donald RR et al. Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. Int J Tuberc Lung Dis 2006; 10(7):802-807.
23. Cutler RR, Wilson P, Villarroel J and Clarke FV. Evaluating current methods for determination of the susceptibility of mycobacteria to pyrazinamide, conventional, radiometric Bactec and two methods of pyrazinamide testing. Letters in Applied Microbiology 1997; 24:127-132.
24. Singh P, Wesley C, Jadaun GPS et al. Comparative Evaluation of Pyrazinamide Susceptibility testing of Mycobacterium tuberculosis by Lowenstein Jensen Proportion method, BacT/Alert 3D system and Enzymatic Pyrazinamidase Assay. J Clin. Microbiol 2006
25. Denkin S, Volokhov D, Chizhikov V and Zhang Y. Microarray - based pncA genotyping of pyrazinamide - resistant strains of Mycobacterium tuberculosis. J Med Microbiol 2005; 54: 1127-1131.
26. Saravia JC, Applwton SC, Rich ML et al. Retreatment management strategies when first line tuberculosis therapy fails. Int J Tuberc Lung Dis 2005; 9:421-429.